Jaguar Gene Therapy Announces Preclinical Data Presentations at Upcoming American Society of Gene an

- Accepted abstracts include preclinical data on JAG101, an investigational gene therapy designed to address the root cause of Type 1 galactosemiaLAKE FOREST, Ill.--(BUSINESS WIRE)--Jaguar Gene Therapy, a biotechnology company accelerating breakthroughs in gene therapy for patients suffering from severe genetic dise...

Related Keywords

United States ,Washington ,American ,Suku Nagendran ,Michael Hughes ,Sandeep Dhall ,Julie Normart ,National Organization For Rare Disorders ,Emory University ,Jaguar Gene Therapy ,University Of Utah ,Waltere Washington Convention Center ,Information Center ,American Society Of Gene ,American Society ,Cell Therapy ,Annual Meeting ,Convention Center ,Chief Medical Officer ,Jaguar Gene ,Gastrointestinal Diseases ,Associate Director ,Preclinical Programs ,Roundtable Discussion Understanding Type ,Gene Therapy ,National Organization ,Rare Disorders ,Rare Disease ,Rare Diseases ,